This content is machine translated Multiple sclerosis Unexpected side effects when switching from natalizumab to a biosimilar In May 2024, Imperial College Healthcare NHS Trust made extensive preparations to switch 80 patients with highly active, relapsing-remitting multiple sclerosis from an established monoclonal antibody drug to a biosimilar...…
View Post 3 min This content is machine translated Generics market in Switzerland Mepha restructures and looks to 2014 with hope The healthcare system is not only under constant pressure to perform, but also under ever-increasing cost pressure. This also applies to generic drug companies in Switzerland. However, Mepha feels it…
